 |
Subscribe / Renew |
 |
Contact Us |
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
Architecture & Engineering
Subscriber content preview
January 26, 2001
Immunex cautious on Enbrel growth
By SAM BENNETT
Journal Staff Reporter
Journal Staff Reporter
Each week, the Daily Journal of Commerce compiles analyst recommendations on Northwest and U.S. stocks. Stock prices reflect Thursday's close. The Dow gained 83 points to close at 10,730, while the Nasdaq lost 105 points to close at 2,754. The S&P 500 shed 6 points to 1,357.
Analysts use the following guidelines for their recommendations:
. . .
To read this story in full login or purchase a subscription.
Previous columns:
- Direct Focus has healthy outlook, 01-19-2001
- Lattice may gain from cyclical upturn, 01-12-2001
- Amazon moves into slow season, 01-05-2001
- Esterline builds on aerospace share, 12-29-2000
- Coldwater builds "cachet" on the Web, 12-22-2000
- Bush White House benefits Boeing, 12-15-2000
- WaMu poised to expand market share, 12-08-2000
- Planar's panels display profit potential, 12-01-2000